Siemens Healthineers AG

SHL

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2025

    Employees

    73,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,374.0082.20-0.97%
CAC 407,727.9342.55-0.55%
DAX 4023,344.54257.891.12%
Dow JONES (US)41,411.0993.660.23%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,921.9155.82-0.31%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.2593.360.76%
S&P 5005,673.5313.14-0.23%
S&P/ASX 2008,157.8080.20-0.97%
SSE Composite Index3,279.037.62-0.23%

Market Movers